These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11222463)

  • 41. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial.
    Baughman RP; Lower EE; Bradley DA; Raymond LA; Kaufman A
    Chest; 2005 Aug; 128(2):1062-47. PubMed ID: 16100213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.
    Raghu G; Brown KK; Costabel U; Cottin V; du Bois RM; Lasky JA; Thomeer M; Utz JP; Khandker RK; McDermott L; Fatenejad S
    Am J Respir Crit Care Med; 2008 Nov; 178(9):948-55. PubMed ID: 18669816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
    Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
    Tyring S; Gottlieb A; Papp K; Gordon K; Leonardi C; Wang A; Lalla D; Woolley M; Jahreis A; Zitnik R; Cella D; Krishnan R
    Lancet; 2006 Jan; 367(9504):29-35. PubMed ID: 16399150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Etanercept. Soluble tumour necrosis factor receptor, TNF receptor fusion protein, TNFR-Fc, TNR 001, Enbrel.
    Drugs R D; 1999 Mar; 1(3):258-61. PubMed ID: 10566040
    [No Abstract]   [Full Text] [Related]  

  • 46. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
    Griffiths CE; Reich K; Lebwohl M; van de Kerkhof P; Paul C; Menter A; Cameron GS; Erickson J; Zhang L; Secrest RJ; Ball S; Braun DK; Osuntokun OO; Heffernan MP; Nickoloff BJ; Papp K;
    Lancet; 2015 Aug; 386(9993):541-51. PubMed ID: 26072109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial.
    Aaron SD; Vandemheen KL; Maltais F; Field SK; Sin DD; Bourbeau J; Marciniuk DD; FitzGerald JM; Nair P; Mallick R
    Thorax; 2013 Feb; 68(2):142-8. PubMed ID: 23161645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
    Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J
    Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
    Smolen JS; Nash P; Durez P; Hall S; Ilivanova E; Irazoque-Palazuelos F; Miranda P; Park MC; Pavelka K; Pedersen R; Szumski A; Hammond C; Koenig AS; Vlahos B
    Lancet; 2013 Mar; 381(9870):918-29. PubMed ID: 23332236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current status of TNF blocking therapy in heart failure.
    Gupta S; Tripathi CD
    Indian J Med Sci; 2005 Aug; 59(8):363-6. PubMed ID: 16129932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etanercept plus standard therapy for Wegener's granulomatosis.
    Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
    N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy.
    Cohen SP; Wenzell D; Hurley RW; Kurihara C; Buckenmaier CC; Griffith S; Larkin TM; Dahl E; Morlando BJ
    Anesthesiology; 2007 Jul; 107(1):99-105. PubMed ID: 17585221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
    de Vlam K; Lories RJ
    Rheumatology (Oxford); 2006 Mar; 45(3):321-4. PubMed ID: 16234275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure.
    Moe GW; Marin-Garcia J; Konig A; Goldenthal M; Lu X; Feng Q
    Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1813-20. PubMed ID: 15205165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in Psoriasis.
    Ikonomidis I; Papadavid E; Makavos G; Andreadou I; Varoudi M; Gravanis K; Theodoropoulos K; Pavlidis G; Triantafyllidi H; Moutsatsou P; Panagiotou C; Parissis J; Iliodromitis E; Lekakis J; Rigopoulos D
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28899951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
    Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
    Geborek P; Crnkic M; Petersson IF; Saxne T;
    Ann Rheum Dis; 2002 Sep; 61(9):793-8. PubMed ID: 12176803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Etanercept (Enbrel) therapy for chronic inflammatory demyelinating polyneuropathy.
    Chin RL; Sherman WH; Sander HW; Hays AP; Latov N
    J Neurol Sci; 2003 Jun; 210(1-2):19-21. PubMed ID: 12736082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.